|
Report Date : |
02.11.2012 |
IDENTIFICATION DETAILS
|
Name : |
THYROCARE
TECHNOLOGIES LIMITED |
|
|
|
|
Registered
Office : |
D-37/1, TTC
Industrial Area, MIDC, Turbhe, Navi Mumbai – 400 703, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2011 |
|
|
|
|
Date of
Incorporation : |
28.01.2000 |
|
|
|
|
Com. Reg. No.: |
11-123882 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.108.094
millions |
|
|
|
|
CIN No.: [Company Identification
No.] |
U85110MH2000PLC123882 |
|
|
|
|
TAN No.: [Tax Deduction &
Collection Account No.] |
MUMT07390F |
|
|
|
|
PAN No.: [Permanent Account No.] |
AABCT2577P |
|
|
|
|
Legal Form : |
A Closely Held Public Limited Liability Company |
|
|
|
|
Line of Business
: |
Providing medical
diagnostics services. |
|
|
|
|
No. of Employees
: |
Information declined by the management |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (50) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 2727000 |
|
|
|
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established and a reputed company having
satisfactory track. Financially company performance is excellent. But the
latest financial of the company is missing from the Government Department. However, fundamental appears to be healthy and strong. General
financial position appears to be good. Trade relations are reported to be
fair. Business is active. Payments are reported to be regular and as per
commitment. The company can be considered for business dealings at usual trade
terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
INDIAN ECONOMIC OVERVIEW
|
Source
: CIA |
RBI DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available RBI Defaulters’ list.
EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS
Subject’s name is not enlisted as a defaulter
in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of
31-03-2012.
INFORMATION DECLINED BY
|
Name : |
Mr. Shadeb |
|
Designation : |
Accounts Executive |
|
Contact No.: |
91-22-67123456 |
|
Date : |
01.11.2012 |
LOCATIONS
|
Registered Office : |
D-37/1, TTC
Industrial Area, MIDC, Turbhe, Navi Mumbai – 400 703, |
|
Tel. No.: |
91-22-67123456/ 30900000/ 27622762 |
|
Fax No.: |
91-22-27682409 |
|
E-Mail : |
|
|
Website : |
DIRECTORS
As on 30.08.2012
|
Name : |
Dr. Velumani Arokiaswamy |
|
Designation : |
Managing Director |
|
Address : |
Row House 87, Hill Garden Row CHS Limited, Opposite Tikujiniwadi,
Chitalsar, |
|
Date of Birth/Age : |
12.04.1958 |
|
Qualification : |
PhD. (Applied Biology) |
|
Date of Appointment : |
28.01.2000 |
|
DIN No.: |
00002804 |
|
|
|
|
Name : |
Mrs. Sumathi Velumani Naidu |
|
Designation : |
Whole-Time Director |
|
Address : |
C/o. of Thyrocare, D-37/1, TTC, MIDC Industrial Area, Navi Mumbai –
400 705, |
|
Date of Birth/Age : |
15.12.1960 |
|
Qualification : |
B. Sc (Chemistry) |
|
Date of Appointment : |
28.01.2000 |
|
DIN No.: |
00002812 |
|
|
|
|
Name : |
Mr. Sundararaju Aarogiasamy Naidu |
|
Designation : |
Whole-Time Director |
|
Address : |
B2/601, Harsiddha Park CHS Limited, Next to Vasant Vihar, Pawar Nagar,
Thane – 400 610, |
|
Date of Birth/Age : |
04.09.1958 |
|
Qualification : |
BA, LLB |
|
Date of Appointment : |
28.01.2000 |
|
DIN No.: |
00003260 |
|
|
|
|
Name : |
Mr. Vivek Chhachhi |
|
Designation : |
Nominee Director |
|
Address : |
TG-2A-2 No.11, Garden Estate, |
|
Date of Birth/Age : |
05.01.1971 |
|
Qualification : |
B. Sc (Computer Science),
MBA Jamnalal Bajaj |
|
Date of Appointment : |
27.12.2010 |
|
DIN No.: |
00496620 |
|
Name of the company or institution whose nominee
the appointee is : |
Agalia Private Limited |
|
|
|
|
Name : |
Mr. Ajay Ramdhan Relan |
|
Designation : |
Nominee Director |
|
Address : |
C-121, Defence Colony, |
|
Date of Birth/Age : |
09.12.1953 |
|
Qualification : |
B.Com
(Economics), PGDM IIM Ahmedabad |
|
Date of Appointment : |
27.12.2010 |
|
DIN No.: |
00002632 |
|
Name of the company or institution whose nominee
the appointee is : |
Agalia Private Limited |
KEY EXECUTIVES
|
Name : |
Mr. Shadeb |
|
Designation : |
Accounts Executive |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 30.08.2012
|
Names of Shareholders |
|
No. of Shares |
|
|
|
|
|
A. Velumani |
|
1741385 |
|
V. Sumathi |
|
130712 |
|
V. Anand |
|
197848 |
|
V. Amruta |
|
170712 |
|
A. Velumani HUF |
|
198324 |
|
A. Sundararaju HUF |
|
649135 |
|
S. Bhamini |
|
1000 |
|
A. Sundararaju |
|
20812 |
|
A. Rathinaswamy |
|
1000 |
|
R. Vasanthamani |
|
1000 |
|
A. Rathinaswamy HUF |
|
1000 |
|
S. Susila |
|
1000 |
|
K. Selvaraj |
|
1000 |
|
P. Arokiaswamy |
|
1001 |
|
A. Sayammal |
|
1001 |
|
Rao Rajgopal J.K. |
|
1000 |
|
Mahima Advertising Private Limited, |
|
315000 |
|
Thyrocate Properties and Infra Private Limited, |
|
1304450 |
|
Navkamna Marketing Private Limited, |
|
787500 |
|
Alexandra Vinimay Private Limited, |
|
700000 |
|
Thyrocare Publication Private Limited, |
|
1633625 |
|
Bennett Coleman and Co, |
|
75000 |
|
Agalia Private Limited, |
|
2598420 |
|
Samara Capital Partners Fund I Limited, |
|
277500 |
|
Total |
|
10809425 |
As on 30.08.2012
|
Equity Share Breakup |
|
Percentage of Holding |
|
Category |
|
|
|
Bodies
corporate |
|
71.15 |
|
Directors
or relatives of directors |
|
21.00 |
|
Other
top fifty shareholders |
|
7.85 |
|
Total |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Providing medical
diagnostics services. |
|
|
|
|
Services : |
v
Diagnostic Services v
Testing Services |
GENERAL INFORMATION
|
No. of Employees : |
Information declined by the management |
|||||||||
|
|
|
|||||||||
|
Bankers : |
Not Available |
|||||||||
|
|
|
|||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
S.D. Khanolkar and Company Chartered Accountants |
|
Address : |
210, Jolly Bhavan No.2, 51, New Marine Lines, Mumbai – 400 020, |
|
Tel. No.: |
91-22-22642569/ 22641399 |
|
E-Mail : |
|
|
|
|
|
Income-tax
PAN of auditor or auditor's firm : |
AAGPK3195A |
|
|
|
|
Associates : |
v Thyrocare
Biotech Private Limited, v Thyrocare
Properties And Infrastructure Private Limited, v Thyrocare
Hospital Limited, v Thyrocare
Diagnostics Private Limited, v Nueclear
Healthcare Limited, v Total T3T4TSH
Diagnostics Private Limited, v Pavilion
Commercial Private Limited, v Navakamna
Marketing Private Limited, v Dee Anu Trading
Co Private Limited, |
|
|
|
|
Joint Ventures : |
v Nueclear Healthcare
Limited, |
CAPITAL STRUCTURE
As on 30.08.2012
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
12000000 |
Equity Shares |
Rs.10/- each |
Rs.120.000 millions |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
10809425 |
Equity Shares |
Rs.10/- each |
Rs.108.094
millions |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
108.094 |
108.094 |
111.124 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
573.718 |
313.144 |
460.152 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
681.812 |
421.238 |
571.276 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.000 |
0.000 |
0.000 |
|
|
2] Unsecured Loans |
250.000 |
0.000 |
0.000 |
|
|
TOTAL BORROWING |
250.000 |
0.000 |
0.000 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
2.227 |
|
|
|
|
|
|
|
|
TOTAL |
931.812 |
421.238 |
573.503 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
161.952 |
150.205 |
196.082 |
|
|
Capital work-in-progress |
0.000 |
1.197 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
240.000 |
0.000 |
16.768 |
|
|
DEFERRED TAX ASSETS |
0.221 |
0.049 |
0.392 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
39.970
|
24.855 |
34.158 |
|
|
Sundry Debtors |
24.518
|
17.909 |
14.401 |
|
|
Cash & Bank Balances |
402.556
|
84.658 |
36.513 |
|
|
Other Current Assets |
7.960
|
5.699 |
49.159 |
|
|
Loans & Advances |
365.500
|
437.079 |
435.351 |
|
Total
Current Assets |
840.504
|
570.200 |
569.582 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
39.182 |
32.858 |
39.481 |
|
|
Other Current Liabilities |
34.555
|
29.558 |
25.683 |
|
|
Provisions |
237.128
|
238.060 |
144.416 |
|
Total
Current Liabilities |
310.865
|
300.476 |
209.580 |
|
|
Net Current Assets |
529.639
|
269.724 |
360.002 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.063 |
0.259 |
|
|
|
|
|
|
|
|
TOTAL |
931.812 |
421.238 |
573.503 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
|
SALES |
|
|
|
|
|
|
|
Operating revenue, net |
772.194 |
583.251 |
452.586 |
|
|
|
Other Income |
38.812 |
68.316 |
11.370 |
|
|
|
TOTAL (A) |
811.006 |
651.567 |
463.956 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Consumption materials changes inventories |
257.545 |
208.147 |
174.286 |
|
|
|
Employee related expenses |
56.100 |
39.387 |
27.497 |
|
|
|
Administrative selling other expenses |
90.955 |
58.371 |
130.754 |
|
|
|
Prior period items before tax |
0.477 |
(1.295) |
0.317 |
|
|
|
TOTAL (B) |
405.077 |
304.610 |
332.854 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
405.929 |
346.957 |
131.102 |
|
|
|
|
|
|
|
|
|
Less |
INTEREST
FINANCIAL EXPENSES (D) |
0.000 |
0.095 |
0.000 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
405.929 |
346.862 |
131.102 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
13.527 |
14.216 |
13.697 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
392.402 |
332.646 |
117.405 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
131.828 |
99.991 |
41.089 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-H) (I) |
260.574 |
232.655 |
76.316 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS YEARS’
BALANCE BROUGHT FORWARD |
3.521 |
20.425 |
19.990 |
|
|
|
|
|
|
|
|
|
|
Amount transferred from free reserves |
0.000 |
13.864 |
0.000 |
|
|
|
|
|
|
|
|
|
Less |
APPROPRIATIONS |
|
|
|
|
|
|
|
Interim Dividend & Tax thereon |
0.000 |
240.283 |
60.881 |
|
|
|
Transfer from General Reserves |
0.000 |
23.140 |
15.000 |
|
|
BALANCE CARRIED
TO THE B/S |
264.095 |
3.521 |
20.425 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Testing services revenues (includes revenues received in Indian rupees
for services rendered for samples received from abroad) |
0.465 |
0.000 |
0.317 |
|
|
TOTAL EARNINGS |
0.465 |
0.000 |
0.317 |
|
|
|
|
|
|
|
|
|
|
IMPORT VALUE |
18.814 |
15.508 |
7.986 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
|
|
|
|
|
|
- Basic |
24.15 |
21.40 |
6.90 |
|
|
|
- Diluted |
23.28 |
21.07 |
7.01 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
PAT / Total Income |
(%) |
32.13
|
35.71 |
16.45 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
50.82
|
57.03 |
25.94 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
39.14
|
46.17 |
15.33 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.58
|
0.79 |
0.21 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
0.82
|
0.71 |
0.37 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
2.70
|
1.90 |
2.72 |
LOCAL AGENCY FURTHER INFORMATION
Details of Sundry Creditors:
|
Particulars |
31.03.2011 (Rs. in millions) |
31.03.2010 (Rs. in millions) |
31.03.2009 (Rs. in millions) |
|
Sundry Creditors |
|
|
|
|
- Creditors due small micro enterprises |
0.000 |
0.000 |
0.000 |
|
- Creditors due others |
39.182 |
32.858 |
39.481 |
|
Total |
39.182 |
32.858 |
39.481 |
|
Check
List by Info Agents |
Available
in Report (Yes / No) |
|
1) Year of Establishment |
Yes |
|
2) Locality of the firm |
Yes |
|
3) Constitutions of the firm |
Yes |
|
4) Premises details |
No |
|
5) Type of Business |
Yes |
|
6) Line of Business |
Yes |
|
7) Promoter’s background |
Yes |
|
8) No. of employees |
No |
|
9) Name of person contacted |
Yes |
|
10) Designation of contact person |
Yes |
|
11) Turnover of firm for last three years |
Yes |
|
12) Profitability for last three years |
Yes |
|
13) Reasons for variation <> 20% |
-- |
|
14) Estimation for coming financial year |
No |
|
15) Capital in the business |
Yes |
|
16) Details of sister concerns |
Yes |
|
17) Major suppliers |
No |
|
18) Major customers |
No |
|
19) Payments terms |
No |
|
20) Export / Import details (if
applicable) |
No |
|
21) Market information |
-- |
|
22) Litigations that the firm / promoter
involved in |
-- |
|
23) Banking Details |
No |
|
24) Banking facility details |
No |
|
25) Conduct of the banking account |
-- |
|
26) Buyer visit details |
-- |
|
27) Financials, if provided |
Yes |
|
28) Incorporation details, if applicable |
Yes |
|
29) Last accounts filed at ROC |
Yes |
|
30) Major Shareholders, if available |
Yes |
|
31)
Date of Birth of Proprietor/Partner/Director, if available |
Yes |
|
32)
PAN of Proprietor/Partner/Director, if available |
No |
|
33)
Voter ID No of Proprietor/Partner/Director, if available |
No |
|
34)
External Agency Rating, if available |
No |
Note:
The registered office of the company has been shifted from Thyrocare House,
Opposite Tikujiniwadi, Thane (West) – 400 086,
RESULTS AND
BUSINESS:
Investments are in
place for more space, more human resources, more automation and more work
loads. The Company is in the process of entering into an arrangement with
diagnostic giant Siemens, for a 1000.000 millions reagent deal. The arrival of
Total Laboratory Automation will enhance their quality, reduce their over
heads, improve the efficiency and further add to the comforts of work force.
The task of
training the franchisees to do quality marketing and operations, their staff to
understand and support the network, improving the number of franchisees in
network and employees in pay roll has been taken in priority by focusing on
‘Class Room Trainings’.
In business growth
front, ‘Enhanced Reach and Quality Marketing’ are the two main areas of focus
for their marketing team in the year to come.
The other focus
areas where resources will be employed includes:
Ø Relationship
with laboratories to explore an enhanced reach.
Ø Funding
diagnostic centres to become partners in preventive care segment.
Ø Financing
hospitals to do higher end tests and give laboratory business to us.
Ø Contracts with
pharma companies for preventive care screening.
Ø Enhancing IT
solutions for network comfort and for employee comfort.
Ø More space for
operations where they can house 25% quarter over quarter growth for next three
years.
Ø Training wisely
for the stake holders in the industry and generate quality manpower.
Ø More automations to laboratory
FIXED ASSETS:
v Land and Building
v Plant and Machinery
v Furniture and Fixtures
v Computer, Software
v Office and Lab Equipments
v Motor Vehicle
WEBSITE DETAILS:
NEWS:
THYROCARE IN DEAL WITH SIEMENS FOR NEW TECHNOLOGY